Developing prognostic models for life expectancy and geriatric outcomes

开发预期寿命和老年结局的预后模型

基本信息

  • 批准号:
    9390251
  • 负责人:
  • 金额:
    $ 17.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-15 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): 1 Prognosis is the risk of an outcome for a condition or disease, such as mortality of mobility impairment. A 2 prognostic index assembles the risk from multiple risk factors to predict outcome more accurately than a single 3 factor would predict on its own. Current prognostic indexes suffer either from being inaccurate, un- 4 interpretable, or both. Consequently, clinicians are unable to accurately determine prognosis in clinical 5 decision making for older adults, often leading to poor outcomes for patients. Many older adults are referred to 6 hospice in the last few hours or days before death, or never at all Other patients are exposed to the harms of 7 cancer screening without the possibility they will live long enough to benefit. Currently available prognostic 8 models estimate risk over a given time frame, such as risk of death over a 4 year period. Clinicians and 9 patients do not think of risk this way, however. They want to know "how long do I have?" This project will 10 address this question by making novel use of the exceptionally long follow up time in the nationally 11 representative National Institute of Aging-funded Health and Retirement Study. The objectives of this project 12 are to use the Health and Retirement Study (HRS) to develop and validate easy-to-use prognostic tools that 13 estimate life-expectancy and time to the onset of disability, inability to manage medications or finances, or 14 mobility impairment. Prognostic tools will be internally validated using the HRS and externally validated 15 using the English Longitudinal Study on Aging (ELSA). This approach leverages the fact that the ELSA was 16 based on the HRS. This project is expected to have a positive impact by informing, individualizing, and 17 improving clinical decision-making in older adults.
 描述(由申请人提供):1预后是一种状况或疾病的结果风险,例如行动不便的死亡率。2个预后指数集合了多个危险因素的风险,比单个3个因素单独预测更准确地预测结果。目前的预后指标要么不准确,要么无法解释,要么两者兼而有之。因此,临床医生无法在老年人的临床决策中准确地判断预后,这往往导致患者的预后不佳。许多老年人在死前的最后几个小时或几天内被转介到临终关怀中心,或者根本没有其他患者在没有可能活到足够长的时间受益的情况下接触到癌症筛查的危害。目前可用的预测模型估计给定时间范围内的风险,例如4年期间的死亡风险。然而,临床医生和9名患者不会以这种方式考虑风险。他们想知道“我还有多长时间?”这个项目10将通过新颖地利用全国11个有代表性的国家老龄化研究所资助的健康和退休研究中超长的后续时间来解决这一问题。项目12的目标是使用健康和退休研究(HRS)开发和验证易于使用的预后工具,这些工具13估计预期寿命和至残疾、无能力管理药物或财务的时间,或14行动障碍。预后工具将使用HRS进行内部验证,并使用英语老龄化纵向研究(ELSA)进行外部验证。这种方法利用了基于HRS的ELSA为16的事实。该项目预计将通过告知、个体化和改善老年人的临床决策而产生积极影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sei Lee其他文献

Sei Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sei Lee', 18)}}的其他基金

Prognostic Indices for Hospitalized Older Adults with and without Alzheimer’s Disease and Related Dementias
患有或不患有阿尔茨海默病和相关痴呆症的住院老年人的预后指数
  • 批准号:
    10740664
  • 财政年份:
    2023
  • 资助金额:
    $ 17.23万
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    9953776
  • 财政年份:
    2021
  • 资助金额:
    $ 17.23万
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    10328473
  • 财政年份:
    2021
  • 资助金额:
    $ 17.23万
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    10616657
  • 财政年份:
    2021
  • 资助金额:
    $ 17.23万
  • 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
  • 批准号:
    9912083
  • 财政年份:
    2018
  • 资助金额:
    $ 17.23万
  • 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
  • 批准号:
    9762780
  • 财政年份:
    2018
  • 资助金额:
    $ 17.23万
  • 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
  • 批准号:
    10308527
  • 财政年份:
    2017
  • 资助金额:
    $ 17.23万
  • 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
  • 批准号:
    9757611
  • 财政年份:
    2017
  • 资助金额:
    $ 17.23万
  • 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
  • 批准号:
    10186503
  • 财政年份:
    2017
  • 资助金额:
    $ 17.23万
  • 项目类别:
Developing prognostic models for life expectancy and geriatric outcomes
开发预期寿命和老年结局的预后模型
  • 批准号:
    9067881
  • 财政年份:
    2015
  • 资助金额:
    $ 17.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了